Navigation Links
Reportlinker Adds Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Date:5/24/2011

NEW YORK, May 24, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

http://www.reportlinker.com/p0511068/Drug-Delivery-Devices-Market-Outlook-in-United-States-to-2017---Metered-Dose-Inhaler-Devices-Infusion-Systems-Central-Venous-Catheters-and-Needle-Free-Injections.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Summary

GlobalData's new report, "Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections" provides key market data on the United States Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the four market categories.

- Global corporate-level profiles of key companies operating within the United States Drug Delivery Devices market.

- Key players covered include GlaxoSmithKline plc, Hospira, Inc., CareFusion Corporation, Boehringer Ingelheim GmbH, AstraZeneca PLC, Baxter International Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the United States Drug Delivery Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 8

1.2 List of Figures 10

2 Introduction 12

2.1 What is This Report About? 12

3 Drug Delivery Devices In United States 13

3.1 Drug Delivery Devices, Market Segmentation 13

3.2 Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017 14

3.3 Drug Delivery Devices Market, United States, Revenue Mix ($m), 2010 16

3.4 Drug Delivery Devices Market, United States, Category Contribution (%), 2010 17

3.5 Drug Delivery Devices, United States, Category Volume (Units), 2003-2017 23

3.6 Drug Delivery Devices, United States, Company Share (2009-2010) 28

4 Central Venous Catheters In United States 30

4.1 Central Venous Catheters, Market Segmentation 30

4.2 Central Venous Catheters Market, United States, Revenue Mix ($m), 2010 31

4.3 Central Venous Catheters Market, United States, Segment Contribution (%), 2010 32

4.4 Central Venous Catheters Overall Revenue (2003-2017) 33

4.5 Central Venous Catheters Overall Volume (2003-2017) 37

4.6 Central Venous Catheters Average Price (2003-2017) 41

4.7 Central Venous Catheters Distribution Share (2009-2010) 42

4.8 Central Venous Catheters, United States, Company Share (2009-2010) 43

5 Infusion Systems In United States 45

5.1 Infusion Systems, Market Segmentation 45

5.2 Infusion Systems Market, United States, Revenue Mix ($m), 2010 46

5.3 Infusion Systems Market, United States, Segment Contribution (%), 2010 47

5.4 Infusion Systems Overall Revenue (2003-2017) 48

5.4.1 Syringe Pumps Revenue (2003-2010) 52

5.4.2 Ambulatory Infusion Pumps Revenue (2003-2010) 56

5.5 Infusion Systems Overall Volume (2003-2017) 60

5.5.1 Syringe Pumps Volume (2003-2010) 64

5.5.2 Ambulatory Infusion Pumps Volume (2003-2010) 66

5.6 Infusion Systems Average Price (2003-2017) 70

5.7 Infusion Systems Distribution Share (2009-2010) 71

5.8 Infusion Systems, United States, Company Share (2009-2010) 72

6 Metered Dose Inhaler Devices In United States 74

6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 74

6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 76

6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 78

6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 79

6.5 Metered Dose Inhaler Devices, United States, Company Share (2009-2010) 80

7 Needle Free Injections In United States 82

7.1 Needle Free Injections Overall Revenue (2003-2017) 82

7.2 Needle Free Injections Overall Volume (2003-2017) 84

7.3 Needle Free Injections Average Price (2003-2017) 86

7.4 Needle Free Injections Distribution Share (2009-2010) 87

7.5 Needle Free Injections, United States, Company Share (2009-2010) 88

8 Overview of Key Companies in United States Drug Delivery Devices Market 90

8.1 GlaxoSmithKline plc 90

8.1.1 Company Overview 90

8.1.2 Share in the United States Drug Delivery Devices Market 90

8.2 Hospira, Inc. 91

8.2.1 Company Overview 91

8.2.2 Share in the United States Drug Delivery Devices Market 91

8.3 CareFusion Corporation 92

8.3.1 Company Overview 92

8.3.2 Share in the United States Drug Delivery Devices Market 92

8.4 Boehringer Ingelheim GmbH 93

8.4.1 Company Overview 93

8.4.2 Share in the United States Drug Delivery Devices Market 93

8.5 AstraZeneca PLC 94

8.5.1 Company Overview 94

8.5.2 Share in the United States Drug Delivery Devices Market 94

8.6 Baxter International Inc. 95

8.6.1 Company Overview 95

8.6.2 Share in the United States Drug Delivery Devices Market 95

8.7 Medtronic, Inc. 96

8.7.1 Company Overview 96

8.8 Teleflex Incorporated 96

8.8.1 Company Overview 96

8.9 Smiths Medical 97

8.9.1 Company Overview 97

8.10 Fresenius Kabi AG 97

8.10.1 Company Overview 97

8.11 B. Braun Melsungen AG 97

8.11.1 Company Overview 97

8.12 Terumo Corporation 98

8.12.1 Company Overview 98

8.13 Consort Medical plc 98

8.13.1 Company Overview 98

8.14 3M Health Care 98

8.14.1 Company Overview 98

8.15 Edwards Lifesciences Corporation 99

8.15.1 Company Overview 99

8.16 Becton, Dickinson and Company 99

8.16.1 Company Overview 99

8.17 Cook Medical Incorporated 99

8.17.1 Company Overview 99

8.18 INJEX - Equidyne Systems 100

8.18.1 Company Overview 100

8.19 Antares Pharma, Inc. 100

8.19.1 Company Overview 100

8.20 Bioject Medical Technologies Inc. 100

8.20.1 Company Overview 100

9 Drug Delivery Devices Market Pipeline Products 101

10 Financial Deals Landscape 108

10.1 Acquisition 108

10.1.1 CarePoint Partners Acquires Premier Infusion 108

10.1.2 SurModics Plans The Sale Of SurModics Pharmaceuticals 109

10.1.3 BTG International To Acquire Biocompatibles 110

10.1.4 Nordson Completes Acquisition Of Micromedics 112

10.1.5 Cardinal Health Sells 13.7% Stake In Carefusion 113

10.1.6 Cellectis Acquires Cyto Pulse Sciences 114

10.2 Partnerships 115

10.2.1 Eli Lilly Enters Into Collaboration With Medtronic 115

10.2.2 West Pharmaceutical Enters Into Agreement With CareFusion 116

10.2.3 Nile Therapeutics Enters Into An Agreement With Medtronic 117

10.2.4 Hospira Enters Into An Agreement With Smiths Medical 118

10.2.5 AorTech International Enters Into Technology License Agreement 119

11 Recent Developments 120

11.1 Strategy and Business Planning 120

11.1.1 Nov 01, 2010: HepaLife Launches Alliqua To Focus On Development, Manufacturing And Marketing Of Proprietary Transdermal Drug Delivery Products 120

11.1.2 Oct 14, 2010: SurModics Announces Organizational Changes To Reduce Cost Structure And Renew Focus On Business Units 121

11.1.3 Aug 31, 2010: Vetter Opens New Sales Office At Illinois Science + Technology Park In Suburban Chicago 122

11.1.4 Aug 19, 2010: Archimedes Pharma Announces New US Headquarters In Bedminster, New Jersey 122

11.1.5 Aug 10, 2010: CareFusion Announces Company-Wide Restructuring 123

11.1.6 Jul 14, 2010: GE Healthcare To Shut Down Two Offices In Waukesha 123

11.1.7 Jul 01, 2010: Shionogi Announces Reorganization Of US Operations 123

11.1.8 Jun 02, 2010: B. Braun Announces Construction Of New Infusion Technology Facility In Melsungen, Germany 124

11.2 Legal and Regulatory 124

11.2.1 Mar 16, 2011: Tekmira Sues Alnylam Pharmaceuticals For Repeated Misuse Of Trade Secrets And Confidential Information 124

11.2.2 Feb 11, 2011: University Of Florida Research Foundation Initiates Court Case Against Diamyd Medical 125

11.2.3 Nov 23, 2010: B. Braun Wins Patent Infringement Case Against Terumo For Introcan Safety IV Catheter 125

11.2.4 Nov 09, 2010: Greenberg Traurig And Segal McCambridge Singer & MahoneyObtain Three Defense Verdicts For I-Flow In Oregon Infusion Pump Cases 126

11.2.5 Nov 03, 2010: Protein Sciences Reports Settlement With Emergent BioSolutions 126

11.2.6 Sep 03, 2010: BioSphere Agrees To Settle Suit Over Merit Medical merger 126

11.2.7 Jul 30, 2010: Federal Appeals Court Rules In Favor Of Covidien In Needle Patents Suit 126

11.2.8 Jul 23, 2010: BioSphere Names In Class Action By Shareholders: SEC Filing 127

11.2.9 Jun 10, 2010: I-Flow Resolves Patent Infringement, Trade Secret Litigation Against Apex Medical Technologies, Zone Medical 127

11.3 Government and Public Interest 127

11.3.1 Mar 16, 2011: Syracuse University Scientists Develop New Drug Delivery System To Improve Cancer Treatment 127

11.3.2 Feb 17, 2011: Delcath Achieves ISO 13485 Certification 128

11.3.3 Dec 20, 2010: BD Diagnostics Facility In Mebane, North Carolina Achieves LEED Silver Certification For Green Building Design 129

11.3.4 Oct 26, 2010: GERES Study Confirms Passive Safety Devices Are Most Effective In Needlestick Injury Prevention 129

11.3.5 Aug 31, 2010: Purdue University Researchers Develop New Pump For Microneedle Drug-Delivery Patch 130

11.3.6 Aug 09, 2010: Talecris Biotherapeutics And Grifols Receive FTC Request For Additional Information Regarding Proposed Merger 131

11.3.7 Jun 14, 2010: Electronic Cigarettes Are Drug Delivery Devices And Should Be Subject To FDA Regulations: AMA 132

11.4 Product News 132

11.4.1 Jul 27, 2010: Dentistry Today Selects Milestone's STA Single Tooth Anesthesia System For Top 100 Products Award Program 132

11.4.2 Jul 13, 2010: Baxter Announces Final Details Regarding Previously Communicated COLLEAGUE Infusion Pump Recall In US 133

11.4.3 Jul 08, 2010: Bioject Announces Use Of Its Intradermal Needle-Free Delivery System In World Health Organization Clinical Trial In Oman With Poliovirus Vaccine 134

12 Appendix 135

12.1 Definitions of Markets Covered in the Report 136

12.1.1 Drug Delivery Devices 136

12.2 Research Methodology 138

12.3 Secondary Research 139

12.4 Primary Research 139

12.5 Models 140

12.6 Forecasts 140

12.7 Expert Panels 140

12.8 GlobalData Consulting 140

12.9 Currency Conversion 141

12.10 Contact Us 141

12.11 Disclaimer 141

1.1 List of Tables

Table 1: Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017 15

Table 2: Drug Delivery Devices Market, United States, Category Contribution (%), 2010 17

Table 3: Drug Delivery Devices, United States, Cross-Category Analysis, 2003-2017 18

Table 4: Drug Delivery Devices, United States, Overall Revenue ($m), Historic, 2003-2010 20

Table 5: Drug Delivery Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 22

Table 6: Drug Delivery Devices, United States, Category Volume (Units), 2003-2017 23

Table 7: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2003-2010 25

Table 8: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2010-2017 27

Table 9: Drug Delivery Devices, United States, Company Share by Revenue ($m), 2009-2010 29

Table 10: Central Venous Catheters Market, United States, Segment Contribution (%), 2010 32

Table 11: Central Venous Catheters, United States, Revenue ($m) by Segment, Historic, 2003-2010 34

Table 12: Central Venous Catheters, United States, Revenue ($m) by Segment, Forecast, 2010-2017 36

Table 13: Central Venous Catheters, United States, Volume (Units) by Segment, Historic, 2003-2010 38

Table 14: Central Venous Catheters, United States, Volume (Units) by Segment, Forecast, 2010-2017 40

Table 15: Central Venous Catheters, United States, Average Price ($), Historic, 2003-2010 41

Table 16: Central Venous Catheters, United States, Average Price ($), Forecast, 2010-2017 41

Table 17: Central Venous Catheters, United States, Distribution Share by Revenue ($m), 2009-2010 42

Table 18: Central Venous Catheters, United States, Company Share by Revenue ($m), 2009-2010 44

Table 19: Infusion Systems Market, United States, Segment Contribution (%), 2010 47

Table 20: Infusion Systems, United States, Revenue ($m) by Segment, Historic, 2003-2010 49

Table 21: Infusion Systems, United States, Revenue ($m) by Segment, Forecast, 2010-2017 51

Table 22: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 53

Table 23: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 55

Table 24: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 57

Table 25: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 59

Table 26: Infusion Systems, United States, Volume (Units) by Segment, Historic, 2003-2010 61

Table 27: Infusion Systems, United States, Volume (Units) by Segment, Forecast, 2010-2017 63

Table 28: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 64

Table 29: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65

Table 30: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 67

Table 31: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69

Table 32: Infusion Systems, United States, Average Price ($), Historic, 2003-2010 70

Table 33: Infusion Systems, United States, Average Price ($), Forecast, 2010-2017 70

Table 34: Infusion Systems, United States, Distribution Share by Revenue ($m), 2009-2010 71

Table 35: Infusion Systems, United States, Company Share by Revenue ($m), 2009-2010 73

Table 36: Metered Dose Inhaler Devices, United States, Revenue ($m) Historic, 2003-2010 74

Table 37: Metered Dose Inhaler Devices, United States, Revenue ($m) Forecast, 2010-2017 75

Table 38: Metered Dose Inhaler Devices, United States, Volume (Units) Historic, 2003-2010 76

Table 39: Metered Dose Inhaler Devices, United States, Volume (Units) Forecast, 2010-2017 77

Table 40: Metered Dose Inhaler Devices, United States, Average Price ($), Historic, 2003-2010 78

Table 41: Metered Dose Inhaler Devices, United States, Average Price ($), Forecast, 2010-2017 78

Table 42: Metered Dose Inhaler Devices, United States, Distribution Share by Revenue ($m), 2009-2010 79

Table 43: Metered Dose Inhaler Devices, United States, Company Share by Revenue ($m), 2009-2010 81

Table 44: Needle Free Injections, United States, Revenue ($m) Historic, 2003-2010 82

Table 45: Needle Free Injections, United States, Revenue ($m) Forecast, 2010-2017 83

Table 46: Needle Free Injections, United States, Volume (Units) Historic, 2003-2010 84

Table 47: Needle Free Injections, United States, Volume (Units) Forecast, 2010-2017 85

Table 48: Needle Free Injections, United States, Average Price ($), Historic, 2003-2010 86

Table 49: Needle Free Injections, United States, Average Price ($), Forecast, 2010-2017 86

Table 50: Needle Free Injections, United States, Distribution Share by Revenue ($m), 2009-2010 87

Table 51: Needle Free Injections, United States, Company Share by Revenue ($m), 2009-2010 89

Table 52: Drug Delivery Devices Market Pipeline Products 101

Table 53: CarePoint Partners Acquires Premier Infusion 108

Table 54: SurModics Plans The Sale Of SurModics Pharmaceuticals 109

Table 55: BTG International To Acquire Biocompatibles 110

Table 56: Nordson Completes Acquisition Of Micromedics 112

Table 57: Cardinal Health Sells 13.7% Stake In Carefusion 113

Table 58: Cellectis Acquires Cyto Pulse Sciences 114

Table 59: Eli Lilly Enters Into Collaboration With Medtronic 115

Table 60: West Pharmaceutical Enters Into Agreement With CareFusion 116

Table 61: Nile Therapeutics Enters Into An Agreement With Medtronic 117

Table 62: Hospira Enters Into An Agreement With Smiths Medical 118

Table 63: AorTech International Enters Into Technology License Agreement 119

Table 64: USD to Local Currency, United States, Average Actual Rate 2003-2010 141

1.2 List of Figures

Figure 1: Drug Delivery Devices, Market Segmentation 13

Figure 2: Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017 14

Figure 3: Drug Delivery Devices Market, United States, Revenue Mix ($m), 2010 16

Figure 4: Drug Delivery Devices Market, United States, Category Contribution (%), 2010 17

Figure 5: Drug Delivery Devices, United States, Cross-Category Analysis, 2003-2017 18

Figure 6: Drug Delivery Devices, United States, Overall Revenue ($m), Historic, 2003-2010 19

Figure 7: Drug Delivery Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 21

Figure 8: Drug Delivery Devices, United States, Category Volume (Units), 2003-2017 23

Figure 9: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2003-2010 24

Figure 10: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2010-2017 26

Figure 11: Drug Delivery Devices, United States, Company Share (%), 2010 28

Figure 12: Central Venous Catheters, Market Segmentation 30

Figure 13: Central Venous Catheters Market, United States, Revenue Mix ($m), 2010 31

Figure 14: Central Venous Catheters Market, United States, Segment Contribution (%), 2010 32

Figure 15: Central Venous Catheters, United States, Revenue ($m) by Segment, Historic, 2003-2010 33

Figure 16: Central Venous Catheters, United States, Revenue ($m) by Segment, Forecast, 2010-2017 35

Figure 17: Central Venous Catheters, United States, Volume (Units) by Segment, Historic, 2003-2010 37

Figure 18: Central Venous Catheters, United States, Volume (Units) by Segment, Forecast, 2010-2017 39

Figure 19: Central Venous Catheters, United States, Company Share (%), 2010 43

Figure 20: Infusion Systems, Market Segmentation 45

Figure 21: Infusion Systems Market, United States, Revenue Mix ($m), 2010 46

Figure 22: Infusion Systems Market, United States, Segment Contribution (%), 2010 47

Figure 23: Infusion Systems, United States, Revenue ($m) by Segment, Historic, 2003-2010 48

Figure 24: Infusion Systems, United States, Revenue ($m) by Segment, Forecast, 2010-2017 50

Figure 25: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 52

Figure 26: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 54

Figure 27: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 56

Figure 28: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 58

Figure 29: Infusion Systems, United States, Volume (Units) by Segment, Historic, 2003-2010 60

Figure 30: Infusion Systems, United States, Volume (Units) by Segment, Forecast, 2010-2017 62

Figure 31: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 64

Figure 32: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65

Figure 33: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 66

Figure 34: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68

Figure 35: Infusion Systems, United States, Company Share (%), 2010 72

Figure 36: Metered Dose Inhaler Devices, United States, Revenue ($m) Historic, 2003-2010 74

Figure 37: Metered Dose Inhaler Devices, United States, Revenue ($m) Forecast, 2010-2017 75

Figure 38: Metered Dose Inhaler Devices, United States, Volume (Units) Historic, 2003-2010 76

Figure 39: Metered Dose Inhaler Devices, United States, Volume (Units) Forecast, 2010-2017 77

Figure 40: Metered Dose Inhaler Devices, United States, Company Share (%), 2010 80

Figure 41: Needle Free Injections, United States, Revenue ($m) Historic, 2003-2010 82

Figure 42: Needle Free Injections, United States, Revenue ($m) Forecast, 2010-2017 83

Figure 43: Needle Free Injections, United States, Volume (Units) Historic, 2003-2010 84

Figure 44: Needle Free Injections, United States, Volume (Units) Forecast, 2010-2017 85

Figure 45: Needle Free Injections, United States, Company Share (%), 2010 88

Figure 46: GlaxoSmithKline plc, Company Share (%),United States Drug Delivery Devices Market, 2010 90

Figure 47: Hospira, Inc., Company Share (%),United States Drug Delivery Devices Market, 2010 91

Figure 48: CareFusion Corporation, Company Share (%),United States Drug Delivery Devices Market, 2010 92

Figure 49: Boehringer Ingelheim GmbH, Company Share (%),United States Drug Delivery Devices Market, 2010 93

Figure 50: AstraZeneca PLC, Company Share (%),United States Drug Delivery Devices Market, 2010 94

Figure 51: Baxter International Inc., Company Share (%),United States Drug Delivery Devices Market, 2010 95

Companies MentionedGlaxoSmithKline plc

Hospira, Inc.

CareFusion Corporation

Boehringer Ingelheim GmbH

AstraZeneca PLC

Baxter International Inc.

Medtronic, Inc.

Teleflex Incorporated

Smiths Medical

Fresenius Kabi AG

B. Braun Melsungen AG

Terumo Corporation

Consort Medical plc

3M Health Care

Edwards Lifesciences Corporation

Becton, Dickinson and Company

Cook Medical Incorporated

INJEX - Equidyne Systems

Antares Pharma, Inc.

Bioject Medical Technologies Inc.

To order this report:

Drug Delivery Technology Industry: Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Drug Delivery Technology Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds Pharmaceuticals Industry Report - Top 500 Pharmaceuticals Industry Report (Global)
2. Reportlinker Adds Antibiotic Manufacturers - Top 150 Antibiotic Manufacturers (Global)
3. Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
4. Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis
5. Reportlinker Adds Triple Analysis: Lymphoma, Melanoma and Peptides
6. Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Peptides
7. Reportlinker Adds Advanced Digital Medical Equipment Products Market
8. Reportlinker Adds India Medical Devices Manufacturers, Distributors and Exporters Directory 2011
9. Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market
10. Reportlinker Adds Orphan Drugs in Asia 2011
11. Reportlinker Adds Global Water Market Outlook: Strategic Analysis of Water and Wastewater Management in the Pharmaceutical Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)... , April 28, 2016 ... "Global Plastic Surgery Products Market 2016-2020" report ... ) , The global plastic surgery ... of 9.47% during the period 2016-2020. , ,The growing ... leading to the growth of the market. Lasers are ...
(Date:4/28/2016)... 28, 2016 Treato , ... healthcare, announced today that it has been named a ... Vendor in Life Sciences, 2016, Stephen Davies ... report focuses on life-science- oriented analytics, algorithms and smart ... and doctors, confirm medication ingestion, and analyze unstructured information. ...
Breaking Medicine Technology:
(Date:4/29/2016)... Newport Beach, Calif. (PRWEB) , ... April 29, 2016 , ... ... affect us. An effective way to confront and deal with these stressors is to ... taste bad to be good for you. Risa Groux, a certified Holistic Nutritionist and ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... more flexibility in repaying their loans, more information about their loan terms and ... total outstanding student loan debt, including federal and private loans, has reached $1.3 ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Spine Team ... pain, is proud to announce one of their physicians has been invited to be ... Physicians (Texas ACOFP) Family Practice Review conference on April 30, 2016. , Dr. ...
(Date:4/29/2016)... ON (PRWEB) , ... April 29, 2016 , ... ... and the Canadian Celiac Association (CCA), is pleased to announce the launch of ... gluten-free products, nutritional articles, recipes, and more. The purpose of the GFCP ...
(Date:4/29/2016)... ... , ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a ... throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , ... patented safety device secured by nasal surgeons onto the floor of the nasal passages, ...
Breaking Medicine News(10 mins):